Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2002

View Archived Issues

New data on the antioxidant capacity of phytochemicals

Daiichi updates status of quinolone antibacterial agents

Rights to angiotensin II receptor blocker for glaucoma licensed to Santen

Pioglitazone normalizes increased retinal leukocyte entrapment in diabetes

Cannabinoid agonist reduces IOP by decreasing aqueous humor flow

PKC-beta inhibition as an approach to the treatment of diabetic macular edema

Adenoviral gene transfer of PEDF inhibits choroidal neovascularization in animal models

CRF antagonists may be useful in the treatment of anxiety and affective disorders

Possible beneficial effects of GABA uptake inhibition on micturition

The health benefits of cranberries

Potent inhibitors of bacterial methionyl-tRNA synthetase active against Gram-positive pathogens

Immusol and Vertex collaborate on discovery of inflammation targets

Applied Molecular Evolution and Centocor sign antibody therapeutic optimization agreement

Design and SAR of new dual H1/H3 antagonists reported at ACS meeting

Kosan awarded SBIR grant for epothilone analogues

Ilex and Abgenix collaborate to develop antibody therapy for cancer

G-207 designated orphan drug in malignant glioma

Amgen acquires filgrastim and pegfilgrastim in Europe from Roche

IND approved for clinical trials of buccal morphine

FDA requests Provenge composition information from Dendreon

Dual CCR3 modulators/H1 antagonists designed at AstraZeneca

Roche patents new series of lanosterol synthase inhibitors

Trk tyrosine kinase inhibitors useful for cancer and pain according to GSK patent

Recent Chiron patent covers new pyridine and pyrimidine GSK3 inhibitors

New analgesics in the Gruenenthal pipeline

Uroselective alpha1-adrenoceptor blockers designed at Recordati

Inhibitors of cyclin-dependent kinases useful as antitumor agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...